"This work is also personally significant. My family has been directly impacted by prostate cancer — my father lives with the disease, and the future risk to my three sons is very real," said new board member Allison Rossiter.
Ex-Novartis leader joins the board of emerging nuclear medicine company
July 17, 2026 Latest NewsAustralian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
Injunction blocks generic launch of key HIV combination medicine
August 6, 2026 - - Latest News -
Moderna begins Phase 1 trial of vaccine candidate against Bundibugyo Ebola Virus
August 6, 2026 - - Latest News -
Neuren reports record DAYBUE sales as royalties rise and global expansion nears
August 6, 2026 - - Australian Biotech -
NSW urged to think pharmacy first as 250 pharmacists near completion of advanced training
August 6, 2026 - - Latest News -
If Australian companies shun their domestic market, who can blame multinationals?
August 6, 2026 - - Latest News -
The complete absence of patient power and agency makes this a health system outlier
August 4, 2026 - - Latest News -
Pharmac announces plan to revise its recently expanded patient advisory function
August 4, 2026 - - Latest News

